UPDATE 1-Amneal, Impax win U.S. deal approval with conditions [Reuters]
IMPAX LABORATORIES (IPXL)
Last impax laboratories earnings: 3/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.impaxlabs.com/investor-relations/default.aspx
Company Research
Source: Reuters
UPDATE 1-Amneal, Impax win U.S. deal approval with conditions | Reuters Reuters Staff 2 Min Read (Recasts, adds background) By Diane Bartz WASHINGTON, April 27 (Reuters) - Generics drug companies Amneal Pharmaceuticals LLC and Impax Laboratories Inc have won U.S. antitrust approval to merge, the U.S. Federal Trade Commission said on Friday. The $1.45 billion deal was approved on condition that the companies sell 10 Impax products, including extended release aspirin, azelastine nasal spray for allergies and an antibiotic, erythromycin tablets, the FTC said in a statement. Under the terms of the proposed settlement, the FTC said ANI Pharmaceuticals Inc will acquire seven products, Perrigo Company Plc will acquire Impax’s rights to two products that it had partnered with Impax to manufacture and sell, and G&W Laboratories Inc will acquire Impax’s marketing rights to one product that G&W manufactures for Impax. The deal, which was announced in October, comes at a time when speedy approval
Show less
Read more
Impact Snapshot
Event Time:
IPXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPXL alerts
High impacting IMPAX LABORATORIES news events
Weekly update
A roundup of the hottest topics